![PDF) Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety PDF) Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety](https://www.researchgate.net/profile/Niklas-Cyril-Hansen/publication/375083933/figure/fig3/AS:11431281202101373@1698723127949/Estimated-mean-change-in-Spherical-Equivalent-Refraction-pr-visit-divided-by_Q320.jpg)
PDF) Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety
Myopia Control with Low-Dose Atropine in European Children: Six-Month Results from a Randomized, Double-Masked, Placebo-Controll
![Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety | BMC Ophthalmology Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety | BMC Ophthalmology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12886-023-03177-9/MediaObjects/12886_2023_3177_Fig1_HTML.png)
Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety | BMC Ophthalmology
![Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety | BMC Ophthalmology Safety and efficacy of 0.01% and 0.1% low-dose atropine eye drop regimens for reduction of myopia progression in Danish children: a randomized clinical trial examining one-year effect and safety | BMC Ophthalmology](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12886-023-03177-9/MediaObjects/12886_2023_3177_Fig3_HTML.png)